A grave neurodegenerative disease like Alzheimer’s whose cure is still unknown can now be managed with Dthera Sciences’ DTHR-ALZ, a novel digital therapy device which has been bestowed with the prestigious Breakthrough Device designation by the FDA.
New research by the University of South Australia in partnership with the University of Stuttgart, Flinders University and the Max Planck Institute for Informatics in Germany have developed hi-tech machine-learning algorithms to reveal a connection between personality and eye movements.
The opening of a new Biomedical Blockchain Research Center was announced by the Icahn School of Medicine at Mount Sinai and the Institute for Next Generation Healthcare which aims to solve healthcare and medical science issues with new technologies and data.
In the latter part of this year, a code of conduct for the use of artificial intelligence (AI) in healthcare will be introduced by the NHS, England, announced Harpreet Sood, associate CCIO at NHS England, at The King’s Fund’s Digital Health and Care Congress 2018 on 11 July.
San Francisco based Verge Genomics, the Neuroscience based drug discovery company launched in 2015, has raised $32 million in early venture capital financing to bring its AI-generated compounds against Parkinson’s disease and amyotrophic lateral sclerosis (ALS) to clinics within the next three years.
The U.S. Food and Drug Administration approved the first autonomous artificial intelligence diagnostic system, IDx-DR and the University of Iowa Healthcare has become the first healthcare organization to implement it.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.